Angle PLC Announces Preliminary Results

CONTINUED PROGRESS TOWARDS FDA SUBMISSION

OVARIAN CANCER STUDY IN PROGRESS

GUILDFORD, SURREY / ACCESSWIRE / June 25, 2020 / ANGLE plc (AIM:AGL)(OTCQX:ANPCY), a world leading liquid biopsy company, today announces audited preliminary results for the eight months ended 31 December 2019. ANGLE’s accounting reference date has changed from 30 April to 31 December and therefore these Financial Statements are reporting on an eight month period.

Click on, or paste the following link into your web browser, to view the associated PDF document.
http://www.rns-pdf.londonstockexchange.com/rns/0071R_1-2020-6-24.pdf

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

SOURCE: ANGLE plc

View source version on accesswire.com:
https://www.accesswire.com/595180/Angle-PLC-Announces-Preliminary-Results

Staff

Recent Posts

Humana Redefines the Member Experience with Agent Assist Built with Google Cloud

Humana introduces Agent Assist to help member advocates deliver faster, more personalized support, enabled by…

4 hours ago

AssureCare Announces Parth Shah’s Promotion to Senior Vice President of Customer Success and Enterprise AI Delivery

CINCINNATI, Feb. 3, 2026 /PRNewswire/ -- AssureCare® LLC, a leading healthcare technology company delivering an…

4 hours ago

Doxim Scales Utility Payments Team to Support Rapid Market Growth

Doxim's Utility Payments Team will drive seamless, omnichannel billing-to-payments solutions for utilities to bridge the…

4 hours ago

Amplifire Recognized by Brandon Hall Group for Breakthrough AI Authoring Technology

BOULDER, Colo., Feb. 3, 2026 /PRNewswire/ -- Amplifire, the leading adaptive learning platform built on patented…

4 hours ago

Cognision Launches Cognision360™: A Unified Platform Transforming Neurobiomarker Acquisition, Processing, and Analysis in CNS Clinical Trials

LOUISVILLE, Ky., Feb. 3, 2026 /PRNewswire/ -- Cognision today unveiled Cognision360™, a groundbreaking web-based platform that consolidates…

4 hours ago